Risperdal Breast Growth Lawsuits

Sponsored by Hissey-Kientz - Committed to protecting your legal rights.
Call us Toll Free at 866-275-4454 for a FREE Consultation
Help and information about Testosterone lawsuit issues.

Johnson & Johnson to pay millions in first Risperdal lawsuit to go to trial

March 13th, 2015

A Philadelphia jury ordered drug maker Johnson & Johnson to pay $2.5 million to a 20-year old autistic man from Alabama who developed breast tissue after taking Risperdal. The Risperdal lawsuit is the first to receive a jury verdict, which may play a part in thousands of other male breast lawsuits filed against J&J.

Austin Pledger was given Risperdal since he was 8 to treat symptoms of irritability related to autism. Pledger eventually developed size 46 DD breasts due to Risperdal-induced gynecomastia, or male breast tissue growth. Pledger’s doctor testified that he was unaware of the increased risks of gynecomastia associated with Risperdal, and the jury determined that J&J and its subsidiary Janssen Pharmaceuticals did not adequately warn physicians and patients of the risk.

Risperdal has been associated with increased levels of prolactin — the hormone responsible for breast tissue growth — for an indefinite period of time. Janssen and J&J face thousands of Risperdal lawsuits alleging that the companies failed to warn doctors and patients of the risk of breast tissue growth in boys and male adolescents who take Risperdal.


Contact Us Today for a Free Consultation.

I am currently represented by an attorney.
*Required fields